Literature DB >> 35503597

The Benefits and Limitations of Stimulants in Treating ADHD.

David Coghill1,2.   

Abstract

This chapter focusses on the benefits and limitations of stimulant medications in the treatment of ADHD. We highlight the key similarities and differences between the different stimulants used to treat ADHD and briefly discuss mechanisms of action, pharmacokinetics, and pharmacodynamics. We will discuss some of the political, ethical, and moral discussions about the use of stimulants including a consideration of the treatment of subsyndromal ADHD and the use of stimulants as cognitive enhancers. We review the comparative efficacy and effectiveness between stimulants and non-pharmacological treatments for ADHD, between stimulant classes and formulations and between stimulant and non-stimulant medications. We discuss the effects on core symptoms, common associated symptoms, cognition, and more distal outcomes including quality of life and functioning and issues related to tolerance, tolerability and adverse effects. Looking at the clinical implications of these findings, we discuss the importance of measurement-based care in the treatment of ADHD. Finally, we will look at the benefits and limitations of stimulants across several different populations and clinical subgroups.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  ADHD; Amphetamines; Lisdexamfetamine; Methylphenidate; Stimulants

Mesh:

Substances:

Year:  2022        PMID: 35503597     DOI: 10.1007/7854_2022_331

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  57 in total

Review 1.  Annual research review: categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders--implications of recent empirical study.

Authors:  David Coghill; Edmund J S Sonuga-Barke
Journal:  J Child Psychol Psychiatry       Date:  2012-01-31       Impact factor: 8.982

Review 2.  Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.

Authors:  Nicoletta Adamo; Sarah Seth; David Coghill
Journal:  Expert Rev Clin Pharmacol       Date:  2015       Impact factor: 5.045

3.  Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (For).

Authors:  David Coghill
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-09-10       Impact factor: 8.829

Review 4.  Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis.

Authors:  David R Coghill; Sarah Seth; Sara Pedroso; Tatiana Usala; John Currie; Antonella Gagliano
Journal:  Biol Psychiatry       Date:  2013-10-12       Impact factor: 13.382

5.  Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

Authors:  Howard B Abikoff; Benedetto Vitiello; Mark A Riddle; Charles Cunningham; Laurence L Greenhill; James M Swanson; Shirley Z Chuang; Mark Davies; Elizabeth Kastelic; Sharon B Wigal; Lori Evans; Jaswinder K Ghuman; Scott H Kollins; James T McCracken; James J McGough; Desiree W Murray; Kelly Posner; Anne M Skrobala; Tim Wigal
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-10       Impact factor: 2.576

6.  Editorial: Acknowledging complexity and heterogeneity in causality--implications of recent insights into neuropsychology of childhood disorders for clinical practice.

Authors:  David Coghill
Journal:  J Child Psychol Psychiatry       Date:  2014-07       Impact factor: 8.982

7.  Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.

Authors:  Joseph Biederman; Michael C Monuteaux; Thomas Spencer; Timothy E Wilens; Heather A Macpherson; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2008-03-03       Impact factor: 18.112

8.  The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.

Authors:  David R Coghill; Sinead M Rhodes; Keith Matthews
Journal:  Biol Psychiatry       Date:  2007-06-01       Impact factor: 13.382

9.  Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.

Authors:  David R Coghill; Tobias Banaschewski; Peter Nagy; Isabel Hernández Otero; César Soutullo; Brian Yan; Beatriz Caballero; Alessandro Zuddas
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

10.  Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway.

Authors:  David Coghill; Sarah Seth
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2015-11-19       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.